(INNS)
SOTEVTAMAB(INNC)
IMMUNOGLOBULIN G2-KAPPA, ANTI-[HOMO SAPIENS CLU (CLUSTERIN, COMPLEMENT LYSIS INHIBITOR, CLI, SULFATED GLYCOPROTEIN 2, SGP- 2,SP-40, TESTOSTERONE-REPRESSED PROSTATE MESSAGE 2, TRPM-2, APOLIPOPROTEIN J, APOJ, KUB1)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN HUMANIZED (1-443) [VH (HOMO SAPIENS IGHV1-69-2*01 (85.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.10] (26-33.51-58.97-106)) (1-117) -HOMO SAPIENS IGHG2*01 (100%), G2M.. CH2 V45.1 (CH1 (118-215), HINGE 1-12 (216- 227), CH2 V45.1 (278) (228-336), CH3 (337-441), CHS (442- 443)) (118-443)], (131-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') [V-KAPPA (HOMO SAPIENS IGKV4-1*01 (91.9%) -IGKJ2*02 (100%), CDR-IMGT [12.3.8] (27-38.56-58.95- 102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219')]; DIMER (219-219'':220-220'':223- 223'':226-226'')-TETRAKISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE DERIVED FROM CHO-K1, GLYCOFORM ALFA(WHO)
SOTEVTAMABUM(INN)